BACKGROUND: This study aimed to explore issues that might impact on the acceptability and feasibility of offering smokers nicotine containing products either to quit nicotine use altogether by using as a short term means of quitting cigarettes or as a longer term substitute. METHOD: Two small pilot studies, one in the UK (n = 34) involving face to face contact and direct provision of the product, the other in Australia (n = 31) conducted remotely with products sent in the mail. RESULTS: Nicotine lozenges were the most popular products, but significant minorities liked a smokeless product more. Use stimulated interest in quitting, and although many failed to use all the products provided, most were interested in future use, more often to help quit than as a planned long-term substitute. CONCLUSIONS: These studies indicate an untapped interest in the use of substitutes to reduce the harmfulness of smoking. Studies of this sort do not inhibit interest in quitting nicotine altogether, and may facilitate it. The greater the range of products on offer, the more smokers are likely to try a product to quit.
BACKGROUND: This study aimed to explore issues that might impact on the acceptability and feasibility of offering smokers nicotine containing products either to quit nicotine use altogether by using as a short term means of quitting cigarettes or as a longer term substitute. METHOD: Two small pilot studies, one in the UK (n = 34) involving face to face contact and direct provision of the product, the other in Australia (n = 31) conducted remotely with products sent in the mail. RESULTS:Nicotine lozenges were the most popular products, but significant minorities liked a smokeless product more. Use stimulated interest in quitting, and although many failed to use all the products provided, most were interested in future use, more often to help quit than as a planned long-term substitute. CONCLUSIONS: These studies indicate an untapped interest in the use of substitutes to reduce the harmfulness of smoking. Studies of this sort do not inhibit interest in quitting nicotine altogether, and may facilitate it. The greater the range of products on offer, the more smokers are likely to try a product to quit.
Authors: Stephen I Rennard; Elbert D Glover; Scott Leischow; David M Daughton; Penny N Glover; Myra Muramoto; Mikael Franzon; Tobias Danielsson; Björn Landfeldt; Ake Westin Journal: Nicotine Tob Res Date: 2006-08 Impact factor: 4.244
Authors: Nina G Schneider; Chris Cortner; Melanie Justice; Jessica L Gould; Courtney Amor; Neil Hartman; Leonard Kleinman; Richard E Olmstead Journal: Nicotine Tob Res Date: 2008-01 Impact factor: 4.244
Authors: Coral E Gartner; Wayne D Hall; Theo Vos; Melanie Y Bertram; Angela L Wallace; Stephen S Lim Journal: Lancet Date: 2007-06-16 Impact factor: 79.321
Authors: Richard J O'Connor; Kaila J Norton; Maansi Bansal-Travers; Martin C Mahoney; K Michael Cummings; Ron Borland Journal: Harm Reduct J Date: 2011-01-10
Authors: Richard J O'Connor; Kristie M June; Maansi Bansal-Travers; Matthew C Rousu; James F Thrasher; Andrew Hyland; K Michael Cummings Journal: Am J Health Behav Date: 2014-01
Authors: Ron Borland; Lin Li; K Michael Cummings; Richard O'Connor; Kevin Mortimer; Tom Wikmans; Lars Ramstrom; Bill King; Ann McNeill Journal: Harm Reduct J Date: 2012-06-11
Authors: Jianmin Liu; Jingzhu Wang; Andrea Vansickel; Jeffery Edmiston; Donald Graff; Mohamadi Sarkar Journal: Clin Pharmacol Drug Dev Date: 2021-01-27
Authors: Matthew J Carpenter; Kevin M Gray; Amy E Wahlquist; Karen Cropsey; Michael E Saladin; Brett Froeliger; Tracy T Smith; Benjamin A Toll; Jennifer Dahne Journal: Nicotine Tob Res Date: 2021-05-24 Impact factor: 4.244